Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Route Oral Published Dose Context Published trials used 0.25 mg to 30 mg/day
The injection is given directly into the muscle, typically in the thigh or upper arm
Important Safety Reminders Medical Supervision Required: AOD-9604 should only be used under qualified medical supervision Baseline and monitoring laboratory testing is recommended Individual contraindications and health status must be evaluated AOD-9604 is not FDA-approved for any indication Contraindications and Precautions: Pregnancy and breastfeeding (no safety data available) Active malignancy (discuss with oncologist) Pediatric use (not studied in children) Significant organ dysfunction (limited safety data) Report Concerns: Any unexpected symptoms or adverse effects should be reported to your healthcare provider promptly
Research-grade purity: Fit for educational and research use that demands high-quality compounds
Hair changes are common during perimenopause, menopause and other hormonal shifts
